日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bile acid synthesis impedes tumor-specific T cell responses during liver cancer

胆汁酸合成会抑制肝癌期间的肿瘤特异性T细胞反应。

Varanasi, Siva Karthik; Chen, Dan; Liu, Yingluo; Johnson, Melissa A; Miller, Cayla M; Ganguly, Souradipta; Lande, Kathryn; LaPorta, Michael A; Hoffmann, Filipe Araujo; Mann, Thomas H; Teneche, Marcos G; Casillas, Eduardo; Mangalhara, Kailash C; Mathew, Varsha; Sun, Ming; Jensen, Isaac J; Farsakoglu, Yagmur; Chen, Timothy; Parisi, Bianca; Deota, Shaunak; Havas, Aaron; Lee, Jin; Chung, H Kay; Schietinger, Andrea; Panda, Satchidananda; Williams, April E; Farber, Donna L; Dhar, Debanjan; Adams, Peter D; Feng, Gen-Sheng; Shadel, Gerald S; Sundrud, Mark S; Kaech, Susan M

PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor models.

在小鼠肝肿瘤模型中,PolyIC 作为佐剂与抗 VEGF 联合抗 PD-L1 疗法相比,疗效更佳

Ji Yichun, Lu Li-Chun, Zhuang Hao, Liu Yingluo, Gao Yiming, Qin Andre, Lee Jin, Feng Gen-Sheng

A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies

KRAS 突变癌症的蛋白质组学和磷酸化蛋白质组学图谱可确定联合疗法

Zhiwei Liu, Yingluo Liu, Lili Qian, Shangwen Jiang, Xiameng Gai, Shu Ye, Yuehong Chen, Xiaomin Wang, Linhui Zhai, Jun Xu, Congying Pu, Jing Li, Fuchu He, Min Huang, Minjia Tan